No Enforcement Immunity For Testimonials On Immunity Or Claims With 'Alert: No COVID-19 Cure'
Executive Summary
Elderberry syrup marketer Provezza Health targeted review of claims consumers may link to COVID-19 prevention or treatment due to testimonials not dispelled by the firm. FDA and FTC warn CBD firm to discontinue claims noting immunity-boosting is the “best defense” against COVID-19.
You may also be interested in...
Marijuana Proponents’ CBD Recommendations Smell Like COVID-19 Claims To US Regulators
Living Senior claimed its CBD tinctures, oral strips and capsules could help prevent or treat COVID-19. It featured on its website recommendations by Bob Melamede, a cannabinoids, cancer, and DNA repair professor at the University of Colorado, and Richard Cowan, formerly executive director of NORML.
Elderberry Demand Loud But Matherson Organics Silent In NAD Review Of Immune Benefit Claim
The National Advertising Division says it will refer Matherson Organics to regulators for possible enforcement after it failed to provide a substantive response to an inquiry on an Instagram claim that suggested Vitamin Bounty Elderberry Immune Support could help prevent or treat COVID-19.
Like Consumer Health Ad Claims About COVID-19, Customer Testimonials Are False And Misleading
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.